MedTrace Logo

Health Coach Intervention Pilot Study

NCT03080064 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2017-03-15

No results posted yet for this study

Summary

In this mixed methods study, the investigators assessed the feasibility and acceptability of a remote health coach intervention to promote healthful lifestyle behaviors among overweight pregnant women. At one northeastern US clinic, the investigators enrolled 30 overweight (pre-pregnancy BMI≥25 kg/m2) pregnant women at a median gestation of 12.5 weeks (IQR: 11-15) into a one arm intervention trial. The investigators connected participants with a health coach to provide behavioral support to help participants adopt or maintain healthy lifestyle goals during pregnancy. Health coaches contacted participants by phone every 2-3 weeks to monitor goals, and sent emails and text messages to check-in between calls. To assess the intervention, participants completed baseline (N=30) and follow-up surveys at the end of the intervention (N=26), as well as follow-up phone interviews (N=18).

Conditions

  • Satisfaction

Interventions

BEHAVIORAL

Health Coach Intervention

Please see arm description.

Sponsors & Collaborators

  • American Heart Association

    collaborator OTHER

  • Harvard Vanguard Medical Associates

    collaborator OTHER

  • Harvard Pilgrim Health Care

    lead OTHER

Principal Investigators

  • Marie-France Hivert, MD, MMSc · Harvard Pilgrim Health Care Institute

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-07-16
Primary Completion
2016-06-27
Completion
2016-06-27

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03080064 on ClinicalTrials.gov